Literature DB >> 3726421

Relation between diagonal ear lobe crease and ischemic chronic heart disease and the factors of coronary risk.

I Guţiu, C el Rifai, M Mallozi.   

Abstract

The presence of a diagonal ear lobe crease (DELC) was studied in 350 non-selected patients admitted to the Clinic. The overall incidence of DELC was 45%, with a significant increase after the age of 50 years (24.8% before and 59.5% after fifty, p less than 0.001). The relationship between DELC and ischemic chronic heart disease (65% as against 23% in the patients without DELC, p less than 0.001) and with some coronary risk factors: arterial hypertension (40% in patients with DELC, 29% in those without, p less than 0.01), smoking (43%) as against 35% in those without DELC. The relationship with diabetes mellitus and obesity was not significant. A higher incidence of DELC was observed in males (66%) than in females (34%) (p less than 0.02). The lipid profile of patients with DELC presents significant cholesterolemia changes (251 +/- 71 mg as against 232 +/- 70 mg in those without DELC) and a less marked increase in lipemia and beta-lipoproteins. All risk factors presented a net increase in the subjects with bilateral DELC. It is concluded that DELC can be used for selecting asymptomatic subjects in the screening of a possible coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3726421

Source DB:  PubMed          Journal:  Med Interne        ISSN: 0377-1202


  3 in total

1.  Association Between Earlobe Crease and the Metabolic Syndrome in a Cross-sectional Study.

Authors:  Eun Hee Kang; Hee Cheol Kang
Journal:  Epidemiol Health       Date:  2012-08-31

2.  Ear lobe crease: a marker of coronary artery disease?

Authors:  Aris P Agouridis; Moses S Elisaf; Devaki R Nair; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

3.  The prognostic value of the Frank sign.

Authors:  J Prangenberg; E Doberentz; L Johann; B Madea
Journal:  Forensic Sci Med Pathol       Date:  2022-02-18       Impact factor: 2.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.